Pharmstandard International’s Argos Therapeutics, Inc. ARGS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | $83K | Hold |
826,153
| – | – | 0.29% | 6 |
|
|
2018
Q2 | $136K | Hold |
826,153
| – | – | 0.55% | 5 |
|
|
2018
Q1 | $744K | Buy |
826,153
+169,014
| +26% | +$152K | 1.87% | 5 |
|
|
2017
Q4 | $39.4K | Sell |
657,139
-4,975
| -0.8% | -$298 | 40.54% | 1 |
|
|
2017
Q3 | $2.38M | Hold |
662,114
| – | – | 6.93% | 4 |
|
|
2017
Q2 | $4.81M | Hold |
662,114
| – | – | 16.67% | 3 |
|
|
2017
Q1 | $5.98M | Hold |
662,114
| – | – | 15.97% | 3 |
|
|
2016
Q4 | $64.9M | Buy |
+662,114
| New | +$64.9M | 55.88% | 1 |
|